Viatris Inc.
VTRSNASDAQ
Product information
What is Viatris Inc. (VTRS)?
Viatris is a US pharmaceutical company headquartered in Canonsburg, Pennsylvania. Its shares trade on Nasdaq under the ticker VTRS, and the company is included in the S&P 500 index. The company was formed in 2020 through the combination of Mylan and Upjohn, Pfizer's unit of branded medicines whose patents have expired.
Viatris's portfolio includes generic medicines, branded medicines and complex generic products. Among the branded products are medicines such as Lipitor and Viagra, while on the generic side there are many products in cardiovascular, central nervous system, respiratory and immune areas. The EpiPen allergy emergency auto-injector, which came from Mylan, is also among its products. The products reach hospitals, pharmacies and health systems in many regions of the world.
Those following Viatris stock typically watch generic drug price pressure, new product approvals, portfolio simplification and sale decisions, and progress in reducing debt. On the VTRS page at Lzzo.com, the price is shown in US dollars, and the page includes a historical price chart, technical indicators and the data source.
Sources: viatris.com, investor.viatris.com
- Name
- Viatris Inc.
- Symbol
- VTRS
- Market
- Stocks
What to look for in the technical analysis of Viatris Inc.
Moving averages help assess the trend and RSI helps assess momentum. Indicators are calculated from real history; when there is not enough history or the required candle fields are missing, the indicator is not calculated. Past results do not guarantee future performance.
Technical indicators
Calculated from observed daily candles (at least 201 observations). No intraday indicators. Indicators are descriptive, not a buy/sell recommendation.
Investment Return CalculatorWith observed closes over the past year
Loading historical prices…